Viewing Study NCT01498458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-05-07 @ 8:10 AM
Study NCT ID: NCT01498458
Status: COMPLETED
Last Update Posted: 2022-06-10
First Post: 2011-12-21
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Sponsor: GBG Forschungs GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None German Breast Group View
None GBG Forschungs GmbH View
None GBG View
None GBG 62 View
None PazoX View
None Breast Cancer View
None Metastatic Breast Cancer View
None Pazopanib View
None Abraxane View
None Capecitabine View
None Xeloda View